Life sciences, genomics and biotechnology for
health
 Main objectives:
Integrating post-genomic research into the more established
biomedical and biotechnological approaches. Involvement
of key stakeholders e.g. industry, healthcare providers
and physicians, policy makers, regulatory authorities,
patient associations and experts on ethical matters
Thematic
areas:
:: Advanced genomics and its application
for health
:: Combating major diseases
Budget:
| The indicative budget allocated to the Thematic Priority
Life Sciences, genomics and biotechnology for health for
the duration of FP6 is EUR 2514 million distributed
as follows: |
| Advanced genomics and its applications for health: |
1209 |
| Combating major diseases: |
1305 |
|
